Le 16ème Congrès Européen sur le SIDA

Le 16ème Congrès Européen sur le SIDA va s’ouvrir plus tard ce mois-ci.

NAM est ravi d’avoir été sélectionné comme reporter officiel pour ce congrès de la Société clinique européenne sur le SIDA (EACS) et nous travaillerons d’arrache-pied pour partager les nouvelles du congrès avec vous.

Nous couvrirons les recherches essentielles présentées pendant le congrès, nous publierons les nouvelles en ligne et nous enverrons également trois bulletins électroniques de synthèse pendant la conférence.

Vous pouvez vous inscrire pour recevoir en français notre bulletin sur la conférence, gratuitement.

Bulletins

Inscrivez-vous pour nos bulletins électroniques gratuits

NAM's news coverage of the 16th European AIDS Conference has been supported by the European AIDS Clinical Society (EACS), and grants from Gilead Sciences Europe Ltd. and Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co. Inc. NAM's wider conference news reporting services have been supported by Janssen and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.